Today is July 02, 2024. All times in Eastern Daylight Time.
Le partenaire de Medincell, Teva, a présenté de nouvelles données soutenant le passage d’Invega Sustenna® (palmitate de palipéridone) à UZEDY® pour le traitement de la schizophrénie
06/03/2024 - 02:00 AM
BUSINESS WIRE
Thermo Fisher Scientific Opens New GMP-certified Ultra-cold Facility in the EU to Accelerate Advanced Therapies Development
06/03/2024 - 02:00 AM
BUSINESS WIRE
Axway Announces the Signing of Binding Agreements for the Acquisition of Sopra Banking Software
06/03/2024 - 02:00 AM
BUSINESS WIRE
Modern Card Issuing Platforms to Issue 35% of All Payment Cards by 2029, as Banks Begin to Compete on User Experience
06/03/2024 - 02:00 AM
BUSINESS WIRE
Thermo Fisher Scientific opent nieuwe GMP-gecertificeerde ultrakoude faciliteit in de EU om de ontwikkeling van geavanceerde therapieën te versnellen
06/03/2024 - 02:00 AM
BUSINESS WIRE
Sopra Steria: A Significant Milestone Achieved in the Group’s Strategy to Refocus Its Activities on Digital Services and Solutions
06/03/2024 - 02:00 AM
BUSINESS WIRE
Axway annonce la signature d’accords engageants relatifs à l’acquisition de Sopra Banking Software
06/03/2024 - 02:00 AM
BUSINESS WIRE
Medincell’s Partner Teva presented New Data Providing Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) from Invega Sustenna® (paliperidone palmitate)
06/03/2024 - 02:00 AM
BUSINESS WIRE
AM Best to Host Insurance Market Briefing in Amsterdam to Review Challenges and Emerging Issues Facing European Carriers
06/03/2024 - 02:00 AM
BUSINESS WIRE
Discover® Global Network Study Shows 85% of Consumers are Less Likely to Interact with a Business Due to a Poor Payment Experience
06/03/2024 - 02:00 AM
BUSINESS WIRE
1
...
1467
1468
1469
1470
1471
1472
1473
1474
1475
1476
1477
« Previous
Next »